Companies › Inmunotek
3 active drug programs in 7 registered trials: 7 Phase 3; Immunology; next expected readout Dec 2026.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| 10,000 MM09 Purified allergenic extract from mite mixture (Dermatophagoides pteronyssinus and Dermatop | – | Phase 3 | Rhinitis, Allergic; Rhinitis; Allergic Rhinitis | Dec 2026 |
| Grasses and olea allergen extract (MG01 + T517) Purified and polymerized with glutaraldehyde allergen extract adsorbed on aluminum hydroxi | – | Phase 3 | Rhinitis, Allergic | Jan 2027 |
| Purified and polymerized allergen extract (10,000 MG01 + 10,000 T521) Subcutaneous immunotherapy with purified and polymerized grass and cupressaceae allergen e | – | Phase 3 | Rhinitis, Allergic | – |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT04898283 | Purified and polymerized allergen extract (10,000 MG01 + 10,000 T521) | Phase 3 | Rhinitis, Allergic | Immunology | Oct 2026 |
| NCT04898283 | Purified and polymerized allergen extract (10,000 MG01 + 10,000 T521) | Phase 3 | Rhinitis, Allergic | Immunology | Oct 2026 |
| NCT04435990 | 10,000 MM09 | Phase 3 | Rhinitis, Allergic | Immunology | Dec 2026 |
| NCT04891237 | Grasses and olea allergen extract (MG01 + T517) | Phase 3 | Rhinitis, Allergic | Immunology | Jan 2027 |
| NCT07348302 | 10,000 MM09 | Phase 3 | Rhinitis | Immunology | Apr 2029 |
| NCT07904195 | 10,000 MM09 | Phase 3 | Allergic Rhinitis | Immunology | Jul 2029 |
| NCT07904052 | 10,000 MM09 | Phase 3 | Allergic Rhinitis | Immunology | Jul 2029 |
No annotated target.
–
Doron Therapeutics UnicoCell Biomed medac ALK-Abelló Kolon TissueGene
Pipelines of the same shape: areas, drug types, target families, stage and cash runway.
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.